Solicitation of Nominations for Membership on the National Vaccine Advisory Committee, 26238-26240 [2016-10205]
Download as PDF
26238
Federal Register / Vol. 81, No. 84 / Monday, May 2, 2016 / Notices
regarding the burden estimate, below, or
any other aspect of the ICR.
DATES: Comments on the ICR must be
received on or before July 1, 2016.
ADDRESSES: Submit your comments to
Information.CollectionClearance@
hhs.gov or by calling (202) 690–6162.
FOR FURTHER INFORMATION CONTACT:
Information Collection Clearance staff,
Information.CollectionClearance@
hhs.gov or (202) 690–6162.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
document identifier HHS–OS–0990–
New—60D for reference.
Information Collection Request Title:
Evaluation of the Second Decade Project
Community Planning Guide Abstract:
The Office of the Assistant Secretary for
Health (OASH) is requesting approval
from the Office of Management and
Budget (OMB) for an evaluation of the
Second Decade Project Community
Planning Guide.
OASH has a long history of
collaborating with communities to
improve adolescent health outcomes. To
further help communities build an
environment that promotes adolescent
health, OASH recently developed
Promoting Health and Healthy
Development in the Second Decade of
Life: A Planning Guide for Communities
(‘‘the Guide’’). The purpose of the Guide
is to provide an easy to follow tool that
community leaders can use to (1)
establish a community coalition with
broad membership, and (2) develop a
community plan for improving
adolescent health and well-being that
includes multi-impact strategies. To
understand whether and how
community leaders are able to use the
Guide to achieve these two goals, OASH
needs information about the Guide’s
utility and effectiveness. The evaluation
of the Second Decade Project
Community Planning Guide (‘‘the
evaluation’’) is intended to support the
goals of OASH’s Second Decade Project
of helping community leaders
incorporate the needs of children,
adolescents and young adults in
community growth and development
plans, and to improve outcomes of
young adults and adolescents. Five
communities will participate in the
piloting and evaluation of the Guide.
The evaluation will provide OASH with
critical information regarding the
components of the Guide that
community leaders found most useful
and effective in accomplishing their
goals of improving adolescent health
and wellbeing; the compilation and
inclusiveness of the coalitions
implementing the Guide; and the
demographic and environmental context
of these communities. While secondary
data will be collected from sources such
as the U.S. Census Bureau American
Community Survey and Youth Risk
Behavior and National Health Interview
Surveys, these sources do not provide
nuanced information needed by OASH
to understand the contexts in which the
Guide is most effective.
Likely Respondents—Qualitative data
will be collected through semistructured telephone interviews and
through focus groups. Telephone
interviews will be conducted with
community leaders (Community Leader
Interview) in the five pilot sites to
explore how the use of the Guide
supported key leaders in their
development of a diverse coalition and
educating the community about issues
facing adolescents. Focus groups will be
conducted with coalition members
(Coalition Member Focus Groups) from
the five pilot sites to assess how the
Guide facilitated the work of the
coalition to develop a comprehensive
community plan that addresses
critically important adolescent health
issues.
Quantitative data will be collected
through Web-based surveys with
coalition members from the five
communities and with secondary
stakeholders—specifically, adolescent
health experts and state/local health
department officials—selected by
OASH. The Coalition Assessment
Survey will assess coalition members’
perspectives on the usefulness and ease
of implementing the Guide. The
Secondary Stakeholder Survey will
engage Adolescent Health researchers
and practitioners to garner additional
feedback and assessment of the Guide.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
responses per
respondent
Number of
respondents
Form name
Hours per
response
Total burden
hours
50
80
250
50
1
1
1
1
1
1
.25
.5
50
80
63
25
Total ........................................................................................................
srobinson on DSK5SPTVN1PROD with NOTICES
Community Leader Interview (CLI) ................................................................
Coalition Member Focus Group (CFG) .........................................................
Coalition Assessment Survey (CAS) .............................................................
Secondary Stakeholder Survey (SSS) ..........................................................
430
..........................
........................
218
OASH specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Terry S. Clark,
Asst. Information Collection Clearance
Officer.
Solicitation of Nominations for
Membership on the National Vaccine
Advisory Committee
[FR Doc. 2016–10199 Filed 4–29–16; 8:45 am]
BILLING CODE 4150–28–P
National Vaccine Program
Office, Office of the Assistant Secretary
for Health, Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
42 U.S.C. 300aa–5, Section
2105 of the Public Health Service (PHS)
Act, as amended. The National Vaccine
AUTHORITY:
VerDate Sep<11>2014
20:30 Apr 29, 2016
Jkt 238001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\02MYN1.SGM
02MYN1
srobinson on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 84 / Monday, May 2, 2016 / Notices
Advisory Committee (NVAC) is
governed by the provisions of Public
Law 92–463, as amended (5 U.S.C.
Appendix 2), which sets forth standards
for the formation and use of advisory
committees.
SUMMARY: The National Vaccine
Program Office (NVPO), a program
office within the Office of the Assistant
Secretary for Health, Department of
Health and Human Services (HHS), is
soliciting nominations of qualified
candidates to be considered for
appointment as public members to the
NVAC. The activities of this Committee
are governed by the Federal Advisory
Committee Act (FACA). Management
and support services of the NVAC and
its activities are the responsibility of the
NVPO.
The NVAC serves an advisory role,
providing recommendations to the
Assistant Secretary for Health in his/her
capacity as the Director of the National
Vaccine Program, on matters related to
the Program’s responsibilities.
Specifically, the Committee studies and
recommends ways to encourage the
availability of an adequate supply of
safe and effective vaccination products
in the United States; and recommends
research priorities and other measures
to enhance the safety and efficacy of
vaccines. The Committee also advises
the Assistant Secretary for Health in the
implementation of Sections 2102 and
2103 of the PHS Act; and identifies
annually the most important areas of
government and non-government
cooperation that should be considered
in implementing Sections 2102 and
2103 of the PHS Act.
DATES: All nominations for membership
on the Committee must be received no
later than 5:00 p.m. EDT on June 1,
2016, to the address listed below.
ADDRESSES: Hardcopy nominations
should be mailed or delivered to: Bruce
Gellin, M.D., M.P.H., Executive
Secretary, NVAC, Office of the Assistant
Secretary for Health, Department of
Health and Human Services, 200
Independence Avenue SW., Room
715–H, Washington, DC 20201.
Electronic nominations should be
emailed to nvpo@hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Jennifer Gordon, Ph.D., Alternate
Designated Federal Official, NVAC;
Science Advisor, National Vaccine
Program Office, Department of Health
and Human Services, 200 Independence
Avenue SW., Room 733G, Washington,
DC 20201; (202) 260–6619;
Jennifer.Gordon@hhs.gov.
A copy of the Committee charter
which includes the NVAC’s structure
and functions, as well as a list of the
VerDate Sep<11>2014
20:30 Apr 29, 2016
Jkt 238001
current membership, can be obtained by
contacting Dr. Gordon or by accessing
the NVAC Web site at: www.hhs.gov/
nvpo/nvac.
SUPPLEMENTARY INFORMATION:
Committee Function, Qualifications,
and Information Required: As part of an
ongoing effort to enhance deliberations
and discussions with the public on
vaccine and immunization policy,
nominations are being sought for
interested individuals to serve on the
NVAC. Committee members provide
peer review, consultation, advice, and
recommendations to the Assistant
Secretary for Health, in his/her capacity
as the Director of the National Vaccine
Program, on matters related to the
Program’s responsibilities. Individuals
selected for appointment to the NVAC
will serve as voting members. The
NVAC consists of 17 voting members:
15 public members, including the Chair,
and two representative members.
Individuals selected for appointment to
the NVAC can be invited to serve terms
of up to four years. Selection of
members is based on candidates’
qualifications to contribute to the
accomplishment of NVAC’s objectives.
Interested candidates should
demonstrate a willingness to commit
time to NVAC activities and the ability
to work constructively and effectively
on committees.
Public Members: Public members are
individuals who are appointed to the
NVAC to exercise their own
independent, best judgment on behalf of
the government. It is expected that
public members will discuss and
deliberate in a manner that is free from
conflicts of interest. Public members to
the NVAC shall be selected from
individuals who are engaged in vaccine
research or the manufacture of vaccines,
or who are physicians, members of
parent organizations concerned with
immunizations, representatives of state
or local health agencies, or public health
organizations.
Representative Members:
Representative members are individuals
who are appointed to the NVAC to
provide the views of industry or a
special interest group. While they may
be experts in various topic areas
discussed by the Committee, they
should not present their own
viewpoints, but rather those of the
industry or special interest group they
represent. NVAC representative
members shall serve specifically to
represent the viewpoints or perspectives
of the vaccine manufacturing industry
or groups engaged in vaccine research or
the manufacture of vaccines.
This announcement is to solicit
nominations of qualified candidates to
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
26239
fill positions in the public member
category of the NVAC, including
positions that are scheduled to be
vacated during the 2016 calendar year.
Travel reimbursement and
compensation for services provided to
the committee: All voting NVAC
members, public and representatives,
are authorized to receive the prescribed
per diem allowance and reimbursement
for travel expenses that are incurred to
attend meetings and conduct authorized
NVAC-related business, in accordance
with standard government travel
regulations. Members appointed to the
NVAC as public members (see
definition above) also are authorized to
receive a stipend for services provided
at public meetings of the Committee. All
other services that are performed by the
public members outside the Committee
meetings shall be provided without
compensation. Representative members
(see definition above) will serve without
compensation.
Expertise sought for the National
Vaccine Advisory Committee: In
accordance with the charter, persons
nominated for appointment as members
of the NVAC should be among
authorities knowledgeable in areas
related to vaccine safety, vaccine
effectiveness, and vaccine supply. In
order to enhance the diversity of
expertise included in Committee
discussions, NVPO is seeking
nominations of individuals to serve on
the NVAC as public members in the
following disciplines/topic areas:
• Vaccine research and development,
vaccine clinical trials, and vaccine
regulatory science;
• vaccine safety and post-marketing
surveillance;
• vaccine access and financing;
• health information technologies and
immunization information systems;
• immunization program
implementation and management;
• vaccine communications;
How to submit nominations:
Nominations should be typewritten. The
following information is required to be
included in the package of material
submitted for each individual being
nominated for consideration: (1) A letter
of nomination that clearly states the
name and affiliation of the nominee, the
basis for the nomination (i.e., specific
attributes which qualify the nominee for
service in this capacity); and a statement
that the nominee is willing to serve as
a member of the Committee (2) the
nominator’s name, address and daytime
telephone number, home and/or work
address, telephone number, and email
address; (3) a copy of the nominee’s
current curriculum vitae (no longer than
ten pages); and (4) a short biographical
E:\FR\FM\02MYN1.SGM
02MYN1
26240
Federal Register / Vol. 81, No. 84 / Monday, May 2, 2016 / Notices
srobinson on DSK5SPTVN1PROD with NOTICES
sketch (no more than 350 words). All
required documentation must be
received in order for a nomination to be
considered. Please note that nominees
will not receive updates on the status of
their nomination. Information on
nominees appointed to the Committee
by the Department will be posted to the
NVAC Web site (https://www.hhs.gov/
nvpo/nvac/roster/).
Individuals can nominate themselves
for consideration of appointment to the
Committee. All nominations must
include the required information.
Incomplete nominations will not be
processed for consideration. The names
of federal employees should not be
nominated for consideration of
appointment to this Committee.
The Department makes every effort to
ensure that the membership of HHS
federal advisory committees is fairly
balanced in terms of points of view
represented and the committee’s
function. Every effort is made that a
broad representation of geographic
areas, gender, ethnic and minority
groups, and the disabled are given
consideration for membership on HHS
federal advisory committees.
Appointment to this Committee shall be
made without discrimination on the
basis of age, race, ethnicity, gender,
sexual orientation, disability, and
cultural, religious, or socioeconomic
status.
Individuals appointed to serve as
public members of federal advisory
committees are classified as special
government employees (SGEs). SGEs are
government employees for purposes of
the conflict of interest laws. Therefore,
individuals appointed to serve as public
members of NVAC are subject to an
ethics review. The ethics review is
conducted to determine if the
individual has any interests and/or
activities in the private sector that may
conflict with performance of their
official duties as a member of the
NVAC. Individuals appointed to serve
as public members of the NVAC will be
required to disclose information
regarding financial holdings,
consultancies, research grants and/or
contracts, and the absence of an
appearance of a loss of impartiality.
Dated: April 25, 2016.
Bruce Gellin,
Executive Secretary, National Vaccine
Advisory Committee Deputy Assistant
Secretary for Health, Director, National
Vaccine Program Office.
[FR Doc. 2016–10205 Filed 4–29–16; 8:45 am]
BILLING CODE 4150–44–P
VerDate Sep<11>2014
20:30 Apr 29, 2016
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Alcohol
Abuse and Alcoholism.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Alcohol Abuse and Alcoholism.
Date: June 9, 2016.
Closed: 9:00 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Terrace Conference Rooms, 5635 Fishers
Lane, Rockville, MD 20892.
Open: 10:15 a.m. to 4:00 p.m.
Agenda: Presentations and other business
of the council.
Place: National Institutes of Health,
Terrace Conference Rooms, 5635 Fishers
Lane, Rockville, MD 20892.
Contact Person: Abraham P. Bautista,
Ph.D., Executive Secretary, National Institute
on Alcohol Abuse & Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Room
2085, Rockville, MD 20852, 301–443–9737,
bautista@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.niaaa.nih.gov/AboutNIAAA/
AdvisoryCouncil/Pages/default.aspx, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: April 26, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–10145 Filed 4–29–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications/
contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Development of Protein Standards.
Date: May 31, 2016.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W114, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, 9609 Medical Center Drive,
Room 7W238, Bethesda, MD 20892–9750,
240–276–6371, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Member
Conflict SEP.
Date: June 27, 2016.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W530, Rockville, MD 20850 (Telephone
Conference Call).
E:\FR\FM\02MYN1.SGM
02MYN1
Agencies
[Federal Register Volume 81, Number 84 (Monday, May 2, 2016)]
[Notices]
[Pages 26238-26240]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-10205]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Membership on the National
Vaccine Advisory Committee
AGENCY: National Vaccine Program Office, Office of the Assistant
Secretary for Health, Office of the Secretary, Department of Health and
Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
AUTHORITY: 42 U.S.C. 300aa-5, Section 2105 of the Public Health Service
(PHS) Act, as amended. The National Vaccine
[[Page 26239]]
Advisory Committee (NVAC) is governed by the provisions of Public Law
92-463, as amended (5 U.S.C. Appendix 2), which sets forth standards
for the formation and use of advisory committees.
SUMMARY: The National Vaccine Program Office (NVPO), a program office
within the Office of the Assistant Secretary for Health, Department of
Health and Human Services (HHS), is soliciting nominations of qualified
candidates to be considered for appointment as public members to the
NVAC. The activities of this Committee are governed by the Federal
Advisory Committee Act (FACA). Management and support services of the
NVAC and its activities are the responsibility of the NVPO.
The NVAC serves an advisory role, providing recommendations to the
Assistant Secretary for Health in his/her capacity as the Director of
the National Vaccine Program, on matters related to the Program's
responsibilities. Specifically, the Committee studies and recommends
ways to encourage the availability of an adequate supply of safe and
effective vaccination products in the United States; and recommends
research priorities and other measures to enhance the safety and
efficacy of vaccines. The Committee also advises the Assistant
Secretary for Health in the implementation of Sections 2102 and 2103 of
the PHS Act; and identifies annually the most important areas of
government and non-government cooperation that should be considered in
implementing Sections 2102 and 2103 of the PHS Act.
DATES: All nominations for membership on the Committee must be received
no later than 5:00 p.m. EDT on June 1, 2016, to the address listed
below.
ADDRESSES: Hardcopy nominations should be mailed or delivered to: Bruce
Gellin, M.D., M.P.H., Executive Secretary, NVAC, Office of the
Assistant Secretary for Health, Department of Health and Human
Services, 200 Independence Avenue SW., Room 715-H, Washington, DC
20201. Electronic nominations should be emailed to nvpo@hhs.gov.
FOR FURTHER INFORMATION CONTACT: Jennifer Gordon, Ph.D., Alternate
Designated Federal Official, NVAC; Science Advisor, National Vaccine
Program Office, Department of Health and Human Services, 200
Independence Avenue SW., Room 733G, Washington, DC 20201; (202) 260-
6619; Jennifer.Gordon@hhs.gov.
A copy of the Committee charter which includes the NVAC's structure
and functions, as well as a list of the current membership, can be
obtained by contacting Dr. Gordon or by accessing the NVAC Web site at:
www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION:
Committee Function, Qualifications, and Information Required: As
part of an ongoing effort to enhance deliberations and discussions with
the public on vaccine and immunization policy, nominations are being
sought for interested individuals to serve on the NVAC. Committee
members provide peer review, consultation, advice, and recommendations
to the Assistant Secretary for Health, in his/her capacity as the
Director of the National Vaccine Program, on matters related to the
Program's responsibilities. Individuals selected for appointment to the
NVAC will serve as voting members. The NVAC consists of 17 voting
members: 15 public members, including the Chair, and two representative
members. Individuals selected for appointment to the NVAC can be
invited to serve terms of up to four years. Selection of members is
based on candidates' qualifications to contribute to the accomplishment
of NVAC's objectives. Interested candidates should demonstrate a
willingness to commit time to NVAC activities and the ability to work
constructively and effectively on committees.
Public Members: Public members are individuals who are appointed to
the NVAC to exercise their own independent, best judgment on behalf of
the government. It is expected that public members will discuss and
deliberate in a manner that is free from conflicts of interest. Public
members to the NVAC shall be selected from individuals who are engaged
in vaccine research or the manufacture of vaccines, or who are
physicians, members of parent organizations concerned with
immunizations, representatives of state or local health agencies, or
public health organizations.
Representative Members: Representative members are individuals who
are appointed to the NVAC to provide the views of industry or a special
interest group. While they may be experts in various topic areas
discussed by the Committee, they should not present their own
viewpoints, but rather those of the industry or special interest group
they represent. NVAC representative members shall serve specifically to
represent the viewpoints or perspectives of the vaccine manufacturing
industry or groups engaged in vaccine research or the manufacture of
vaccines.
This announcement is to solicit nominations of qualified candidates
to fill positions in the public member category of the NVAC, including
positions that are scheduled to be vacated during the 2016 calendar
year.
Travel reimbursement and compensation for services provided to the
committee: All voting NVAC members, public and representatives, are
authorized to receive the prescribed per diem allowance and
reimbursement for travel expenses that are incurred to attend meetings
and conduct authorized NVAC-related business, in accordance with
standard government travel regulations. Members appointed to the NVAC
as public members (see definition above) also are authorized to receive
a stipend for services provided at public meetings of the Committee.
All other services that are performed by the public members outside the
Committee meetings shall be provided without compensation.
Representative members (see definition above) will serve without
compensation.
Expertise sought for the National Vaccine Advisory Committee: In
accordance with the charter, persons nominated for appointment as
members of the NVAC should be among authorities knowledgeable in areas
related to vaccine safety, vaccine effectiveness, and vaccine supply.
In order to enhance the diversity of expertise included in Committee
discussions, NVPO is seeking nominations of individuals to serve on the
NVAC as public members in the following disciplines/topic areas:
Vaccine research and development, vaccine clinical trials,
and vaccine regulatory science;
vaccine safety and post-marketing surveillance;
vaccine access and financing;
health information technologies and immunization
information systems;
immunization program implementation and management;
vaccine communications;
How to submit nominations: Nominations should be typewritten. The
following information is required to be included in the package of
material submitted for each individual being nominated for
consideration: (1) A letter of nomination that clearly states the name
and affiliation of the nominee, the basis for the nomination (i.e.,
specific attributes which qualify the nominee for service in this
capacity); and a statement that the nominee is willing to serve as a
member of the Committee (2) the nominator's name, address and daytime
telephone number, home and/or work address, telephone number, and email
address; (3) a copy of the nominee's current curriculum vitae (no
longer than ten pages); and (4) a short biographical
[[Page 26240]]
sketch (no more than 350 words). All required documentation must be
received in order for a nomination to be considered. Please note that
nominees will not receive updates on the status of their nomination.
Information on nominees appointed to the Committee by the Department
will be posted to the NVAC Web site (https://www.hhs.gov/nvpo/nvac/roster/). Individuals can nominate themselves for
consideration of appointment to the Committee. All nominations must
include the required information. Incomplete nominations will not be
processed for consideration. The names of federal employees should not
be nominated for consideration of appointment to this Committee.
The Department makes every effort to ensure that the membership of
HHS federal advisory committees is fairly balanced in terms of points
of view represented and the committee's function. Every effort is made
that a broad representation of geographic areas, gender, ethnic and
minority groups, and the disabled are given consideration for
membership on HHS federal advisory committees. Appointment to this
Committee shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, disability, and cultural,
religious, or socioeconomic status.
Individuals appointed to serve as public members of federal
advisory committees are classified as special government employees
(SGEs). SGEs are government employees for purposes of the conflict of
interest laws. Therefore, individuals appointed to serve as public
members of NVAC are subject to an ethics review. The ethics review is
conducted to determine if the individual has any interests and/or
activities in the private sector that may conflict with performance of
their official duties as a member of the NVAC. Individuals appointed to
serve as public members of the NVAC will be required to disclose
information regarding financial holdings, consultancies, research
grants and/or contracts, and the absence of an appearance of a loss of
impartiality.
Dated: April 25, 2016.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee Deputy
Assistant Secretary for Health, Director, National Vaccine Program
Office.
[FR Doc. 2016-10205 Filed 4-29-16; 8:45 am]
BILLING CODE 4150-44-P